Zimmer Biomet Holdings Inc (ZBH.N)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2013||Independent Non-Executive Chairman of the Board|
|50||2017||President, Chief Executive Officer, Director|
|53||2017||Chief Financial Officer, Senior Vice President|
|52||2013||President, Europe, Middle East and Africa|
- BRIEF-Zimmer Biomet Prices Offering Of Senior Notes
- BRIEF-Zimmer Biomet Holdings Files For Offering Of Floating Rate Notes Due 2021
- BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16
- BRIEF-Zimmer Biomet Holdings Announces FDA Clearance Of Sidus Stem-Free Shoulder System
- BRIEF-Zimmer Biomet Says Positive Results From Progress II Trial Of Autologous Protein Solution Prepared With nSTRIDE Aps Kit In Treating Osteoarthritis